ARCHIVES

Studies Link Age-Dependent Outcome To Immune Cells

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

November 26, 2010

In Brief: George Vande Woude To Wistar institute Board; Donald Pinkel To Head Pediatric Leukemia Program

October 18, 1985

NIH Director: NCI’s Special Authorities “More Of A Negative Than A Positive”

June 11, 2010

MRI, 3D Ultrasound Combination Can Guide Prostate Biopsies

December 28, 2012

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

November 27, 1987

Oklahoma Cancer Center Recruits Four Professors.

June 15, 2001